Recent Finacing
Recent Raise
Giiant Pharma, a Montreal-based preclinical biotech, designs gut-restricted small-molecule therapeutics using a Precision Delivery platform that leverages gut microbiota to bioactivate colon-specific prodrugs, including GT-2108 for ulcerative colitis.
